<\/p>\n
Kyiv, July, 2023 <\/strong>\u2013 Global law firm Dentons advised Farmak, Ukraine\u2019s leading pharmaceutical company, on a series of strategic acquisitions from a portfolio company of private equity house Novator. Farmak acquired pharmaceutical marketing companies in the Czech Republic and Slovakia, together with the relevant IP rights and trademarks, and in a separate transaction, a Ukrainian business owning a product portfolio, selected assets, and IP rights and trademarks.<\/p>\n Farmak has a 6% share of the Ukrainian pharmaceutical market and exports its products to more than 50 countries. Through this transaction, Farmak will increase its presence in the European Union while strengthening its position in the cardiology and cough and cold segments.<\/p>\n Counsel Luk\u00e1\u0161 V\u00fdmola <\/strong>(Prague) and partners Adam Mycyk <\/strong>(Kyiv) and Petr Z\u00e1kouck\u00fd <\/strong>(Prague) led Dentons\u2019 cross-practice and cross-jurisdictional team. The team included associates Petr Mueller<\/strong>, Adam P\u0159erovsk\u00fd<\/strong>, \u0160t\u011bp\u00e1nka Havl\u00edkov\u00e1<\/strong>, Blanka Crh\u00e1kov\u00e1<\/strong>, Jan Tyl\u0161<\/strong>, Tom\u00e1\u0161 Jon\u00e1\u0161<\/strong> and Michael Mr\u00e1\u010dek<\/strong> in Prague; partner Juraj Gy<\/strong>\u00e1rf\u00e1\u0161<\/strong> and associates Jan Dulovic<\/strong>, Alen Gondek<\/strong>, Gabriel Kulik<\/strong>, Michal Distler<\/strong> and Tatiana Jev\u010d\u00e1kov\u00e1<\/strong> in Bratislava; partner Maksym Sysoiev<\/strong>, counsel Anna V. Tkachenko<\/strong>, Oksana Horban\u00a0<\/strong>and Evgenia Prudko<\/strong>, and associates Volodymyr Omelchenko<\/strong>, Victor Marchan<\/strong> and Roman Mehedynyuk <\/strong>in Kyiv, partner Rob Irving\u00a0<\/strong>in Budapest, and counsel Clemence Personne <\/strong>in Luxembourg.<\/p>\n Commenting on the transaction, Adam Mycyk <\/strong>said: \u201cWe are very proud to have supported our client\u00b4s strategy to evolve into an international company, drawing on our cross-border M&A, pharmaceutical industry, and IP expertise.\u201d<\/em><\/p>\n Dmytro Shapkin, Chief Transformation Officer at Farmak<\/strong> said: \u201cWe appreciated Dentons\u2019 guidance in successfully closing this deal. We were impressed with the high quality of their legal advice, outstanding commitment, as well as smooth cross-border cooperation.\u201d<\/em><\/p>\n About Dentons<\/strong><\/p>\n Dentons is designed to be different. As the world’s largest law firm with 20,000 professionals in over 200 locations in more than 80 countries, we can help you grow<\/a>, protect<\/a>, operate<\/a> and finance<\/a> your business. Our polycentric and purpose-driven approach, together with our commitment to inclusion, diversity, equity and ESG, ensures we challenge the status quo to stay focused on what matters most to you. www.dentons.com<\/a>.<\/p>\n <\/p>","protected":false},"excerpt":{"rendered":" Kyiv, July, 2023 \u2013 Global law firm Dentons advised Farmak, Ukraine\u2019s leading pharmaceutical company, on a series of strategic acquisitions from a portfolio company of private equity house Novator. Farmak acquired pharmaceutical marketing companies in the Czech Republic and Slovakia, together with the relevant IP rights and trademarks, and in a separate transaction, a Ukrainian […]<\/p>\n","protected":false},"author":4489,"featured_media":488676,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"inline_featured_image":false},"categories":[24,23],"tags":[],"yoast_head":"\n